Walgreens is in particularly awful shape
CNN
Drug stores around the United States are struggling. Especially Walgreens.
Drug stores around the United States are struggling. Especially Walgreens. Walgreens’ stock has plunged more than 80% over the past five years, ranking the company among the worst-performing stocks during that stretch. It’s closing 1,200 stores, roughly 15% of its locations. And now Walgreens is reportedly looking to escape the public market. Walgreens and private equity firm Sycamore Partners are discussing a deal to take Walgreens private, the Wall Street Journal reported Tuesday. The companies declined to comment to CNN on a potential deal. Walgreens’ problem, first and foremost, is that it’s more of a traditional pharmacy than CVS. Walgreens has slipped behind CVS because it’s smaller than CVS, giving it less scale to negotiate prices with insurers and other health care entities that pay for most of the prescriptions people pick up. Walgreens is also more reliant on filling prescriptions through its pharmacy business and selling snacks and household essentials than CVS, which has made a push into health care services. Both the pharmacy business and the retail business are struggling for different reasons. Profits from the pharmacy business have dropped in recent years as reimbursement rates for prescription drugs fall. The prices customers pay for drugs and the payments pharmacies receive are largely determined by companies known as pharmacy benefit managers, or PBMs, which negotiate rebates from drug manufacturers to insurers. PBMs have been cutting reimbursement rates to boost their own profits.
1-star McDonald’s reviews and sympathetic merch: Companies try to stop online support for CEO killer
After police found the words “deny,” “defend” and “depose” printed on shell casings near the site where UnitedHealthcare CEO Brian Thompson was gunned down, merchandise bearing those words started to appear online.